The 10 chapters in this volume, compiled by Masur (immunology and experimental oncology, U. of Witten/Herdecke, Germany), focus on the epidemiological and molecular links between type 2 diabetes and cancer. Scientists and clinicians from Europe, the US, and Israel discuss the pathophysiology of type 2 diabetes, new issues relating to in vivo imaging, incretin-based therapy strategies, the role of glucose and glucose regulating hormones and transporter systems, the "Warburg" effect, nutritional strategies, and the increased risk for breast cancer. The volume is meant for endocrinologists, oncologists, diabetologists, general practitioners, nurses, and life sciences students.